Flow cytometry analysis after treatment revealed a decrease in Treg/CD8+ ratio and an increase in GranB+ CD8+ T cell population in the combination therapy group, revealing the alleviation of immunosuppressive TME and an increase of tumor infiltrating lymphocytes (Fig. 6g, h). Here, CD8A is linked to neoplasm.